drugset / Trial / NCT00819377

Milrinone Inhaled in Cardiac Surgery

NCT00819377

RandomizedParallel-groupDouble-blindTreatment

Summary

Pulmonary hypertension is an important morbidity factor in patients having to undergo cardiac surgery with cardiopulmonary bypass (ECC). Milrinone used in inhalation, shows evidence of being a pulmonary vasodilator able to possibly contribute to the reduction of pressure on the pulmonary artery.

Timeline

Start
2009-02
Primary completion
2012-01
Completion
2012-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Milrinone Small molecule 5 mg Other